Holen Sie sich die Stockscreener-App
8.14
5.68%
-0.49
Vorhandelsmarkt:
7.92
-0.22
-2.70%
Schlusskurs vom Vortag:
$8.63
Offen:
$8.51
24-Stunden-Volumen:
10.48M
Relative Volume:
1.44
Marktkapitalisierung:
$1.44B
Einnahmen:
$2.54B
Nettoeinkommen (Verlust:
$-207.36M
KGV:
-6.8403
EPS:
-1.19
Netto-Cashflow:
$151.25M
1W Leistung:
-9.66%
1M Leistung:
-9.66%
6M Leistung:
+15.30%
1J Leistung:
-11.62%
1-Tages-Spanne:
$7.79
$8.51
1-Wochen-Bereich:
$7.79
$9.15
52-Wochen-Spanne:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Firmenname
Teladoc Health Inc
Sektor
Branche
Telefon
(203) 635-2002
Adresse
155 E 44TH STREET, NEW YORK, NY
Vergleichen Sie TDOC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
8.14 | 1.53B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
292.72 | 47.73B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
88.71 | 15.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.95 | 12.36B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.81 | 8.15B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.03 | 6.86B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Bestätigt | Jefferies | Hold |
| 2024-02-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-17 | Herabstufung | DA Davidson | Buy → Neutral |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-02-23 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Hochstufung | Guggenheim | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-17 | Herabstufung | Guggenheim | Neutral → Sell |
| 2022-08-12 | Eingeleitet | DA Davidson | Buy |
| 2022-08-02 | Herabstufung | Berenberg | Buy → Hold |
| 2022-08-02 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-07-28 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-28 | Herabstufung | Needham | Buy → Hold |
| 2022-07-06 | Bestätigt | BofA Securities | Neutral |
| 2022-05-05 | Herabstufung | Argus | Buy → Hold |
| 2022-04-28 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-28 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2022-04-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-03 | Hochstufung | Argus | Hold → Buy |
| 2022-02-23 | Bestätigt | BofA Securities | Neutral |
| 2022-02-23 | Bestätigt | Craig Hallum | Hold |
| 2022-02-23 | Bestätigt | Evercore ISI | In-line |
| 2022-02-23 | Bestätigt | Goldman | Buy |
| 2022-02-23 | Bestätigt | JP Morgan | Overweight |
| 2022-02-23 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Bestätigt | Needham | Buy |
| 2022-02-23 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2022-02-08 | Bestätigt | Piper Sandler | Overweight |
| 2021-12-02 | Fortgesetzt | Jefferies | Hold |
| 2021-11-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-10-28 | Bestätigt | Barclays | Equal Weight |
| 2021-10-28 | Bestätigt | BofA Securities | Neutral |
| 2021-10-28 | Bestätigt | Canaccord Genuity | Buy |
| 2021-10-28 | Bestätigt | Citigroup | Buy |
| 2021-10-28 | Bestätigt | Craig Hallum | Hold |
| 2021-10-28 | Bestätigt | Needham | Buy |
| 2021-10-28 | Bestätigt | Oppenheimer | Outperform |
| 2021-10-28 | Bestätigt | Piper Sandler | Overweight |
| 2021-10-28 | Bestätigt | UBS | Neutral |
| 2021-10-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-08-02 | Herabstufung | Argus | Buy → Hold |
| 2021-07-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Eingeleitet | Robert W. Baird | Neutral |
| 2021-04-15 | Eingeleitet | Needham | Buy |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-12-22 | Eingeleitet | Evercore ISI | In-line |
| 2020-12-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Eingeleitet | Goldman | Neutral |
| 2020-11-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Eingeleitet | DA Davidson | Buy |
| 2020-09-02 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-17 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-07-13 | Eingeleitet | Argus | Buy |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-04-30 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-03-31 | Herabstufung | Berenberg | Buy → Hold |
| 2020-03-25 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-03-16 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Eingeleitet | UBS | Neutral |
| 2020-01-09 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Teladoc Health Inc Aktie (TDOC) Neueste Nachrichten
Will Teladoc Health Inc. (4LL) stock outperform small cap peersJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
How Teladoc Health Inc. (4LL) stock behaves under inflation pressureTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com
Will Teladoc Health Inc. stock gain from strong economyMarket Growth Summary & Stock Portfolio Risk Control - newser.com
Is This Beaten-Down Stock Finally on the Road to Recovery? - AOL.com
Is This Beaten-Down Stock Finally on the Road to Recovery? - The Motley Fool
Teladoc Stock Drops on Slowing Growth Forecasts | Q3 2025 ResultsNews and Statistics - IndexBox
Why Teladoc (TDOC) Shares Are Getting Obliterated Today - TradingView
Lumeris launches Rural Health Transformation Program coalition - Modern Healthcare
Teladoc Health, Inc.'s (NYSE:TDOC) Prospects Need A Boost To Lift Shares - 富途牛牛
How Teladoc Health Inc. stock valuations compare to rivalsProduct Launch & Weekly High Conviction Ideas - newser.com
Will Teladoc Health Inc. stock return to pre crash levels2025 Buyback Activity & Weekly Chart Analysis and Guides - newser.com
How to integrate Teladoc Health Inc. into portfolio analysis toolsQuarterly Market Summary & Risk Controlled Stock Pick Alerts - newser.com
What momentum shifts mean for Teladoc Health Inc.Weekly Risk Report & Capital Efficiency Focused Strategies - newser.com
Collaborative for Healthy Rural America™ (CHRA) Launches to Transform Rural Healthcare Nationwide - The AI Journal
Has Teladoc Health Inc. found a price floorWeekly Profit Report & Fast Gain Stock Tips - newser.com
How to recover losses in Teladoc Health Inc. stockPortfolio Gains Summary & Fast Exit Strategy with Risk Control - newser.com
Why Teladoc Health Inc. stock could be next big winnerWeekly Profit Analysis & AI Enhanced Trading Alerts - newser.com
Will Teladoc Health Inc. (4LL) stock enhance shareholder valueMarket Sentiment Review & Stock Portfolio Risk Management - newser.com
Telestroke Services Market Hits $1.87 Billion in 2024, Forecast - openPR.com
Will Teladoc Health Inc. stock boost dividends furtherPortfolio Return Report & Real-Time Market Sentiment Alerts - newser.com
How Teladoc Health Inc. stock performs after earningsTrend Reversal & Expert Approved Momentum Ideas - newser.com
How Teladoc Health Inc. (4LL) stock compares with top peersMarket Risk Analysis & Daily Profit Focused Screening - newser.com
Trend analysis for Teladoc Health Inc. this weekTake Profit & Daily Growth Stock Investment Tips - newser.com
Is Teladoc Health Inc. stock a contrarian opportunityAnalyst Upgrade & Daily Profit Focused Stock Screening - newser.com
Should you wait for a breakout in Teladoc Health Inc.July 2025 Summary & Free Technical Confirmation Trade Alerts - newser.com
Leerink Partnrs Forecasts Weaker Earnings for Teladoc Health - MarketBeat
Is Teladoc Health Inc. stock a buy before earnings resultsJuly 2025 Action & Technical Pattern Based Buy Signals - newser.com
Can Teladoc Health Inc. (4LL) stock sustain revenue momentumPortfolio Performance Summary & Community Trade Idea Sharing - newser.com
Order flow analysis tools used on Teladoc Health Inc.Quarterly Investment Review & Real-Time Buy Zone Alerts - newser.com
Does Teladoc Health's (TDOC) Guidance Shift Reflect a New Strategic Growth Focus? - Yahoo Finance
Custom watchlist performance reports with Teladoc Health Inc.Fed Meeting & Intraday High Probability Alerts - newser.com
Finanzdaten der Teladoc Health Inc-Aktie (TDOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
8.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):